| 6th Mar 2024 7:00 am |
RNS |
FY23 Preliminary Results |
| 1st Mar 2024 2:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
| 29th Feb 2024 6:00 pm |
RNS |
Directorate Change |
| 13th Feb 2024 4:00 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
| 2nd Feb 2024 4:30 pm |
RNS |
Holding(s) in Company |
| 1st Feb 2024 12:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
| 22nd Jan 2024 7:00 am |
RNS |
Expansion of leadership team |
| 11th Jan 2024 5:30 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
| 11th Jan 2024 5:30 pm |
RNS |
Employee Stock Purchase Plan - PDMR Notification |
| 9th Jan 2024 7:00 am |
RNS |
FY23 trading update |
| 3rd Jan 2024 7:00 am |
RNS |
Presentation at 42nd Annual J.P. Morgan Conference |
| 19th Dec 2023 2:00 pm |
RNS |
Appointment of Two Non-Executive Directors |
| 12th Dec 2023 5:00 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
| 7th Dec 2023 4:30 pm |
RNS |
Nanopore Community Meeting Technology Update |
| 1st Dec 2023 5:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
| 30th Nov 2023 7:00 am |
RNS |
National Australian rare disease programme |
| 13th Nov 2023 5:00 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
| 13th Nov 2023 12:00 pm |
RNS |
Participation in upcoming investor conferences |
| 7th Nov 2023 8:30 am |
RNS |
Admission to Trading on the London Stock Exchange |
| 6th Nov 2023 7:00 am |
RNS |
Issue of Equity |
| 1st Nov 2023 4:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
| 31st Oct 2023 7:00 am |
RNS |
Apple showcases Oxford Nanopore in M3 launch |
| 26th Oct 2023 6:10 pm |
RNS |
Holding(s) in Company |
| 24th Oct 2023 12:30 pm |
RNS |
Holding(s) in Company |
| 23rd Oct 2023 8:30 am |
RNS |
Admission to Trading on the London Stock Exchange |
| 23rd Oct 2023 8:30 am |
RNS |
Issue of Equity and Total Voting Rights |
| 19th Oct 2023 7:00 am |
RNS |
Capital Markets Day - ONT expands into clinical |
| 19th Oct 2023 7:00 am |
RNS |
bioMérieux makes investment in Oxford Nanopore |
| 19th Oct 2023 7:00 am |
RNS |
Mayo Clinic and Oxford Nanopore collaboration |
| 11th Oct 2023 3:30 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
| 6th Oct 2023 3:00 pm |
RNS |
Block Listing Interim Review |
| 2nd Oct 2023 4:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
| 27th Sep 2023 5:00 pm |
RNS |
Director Declaration |
| 12th Sep 2023 3:00 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
| 12th Sep 2023 7:00 am |
RNS |
Presentation at the Morgan Stanley Conference |
| 6th Sep 2023 7:00 am |
RNS |
Interim results for the 6 months ended 30 June 23 |
| 1st Sep 2023 3:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
| 25th Aug 2023 12:00 pm |
RNS |
Notice of Results and Capital Markets Day |
| 11th Aug 2023 5:00 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
| 1st Aug 2023 5:30 pm |
RNS |
Issue of Equity and Total Voting Rights |
